UPDATE: Jefferies Reiterates Buy Rating, Raises PT on CME Group on 1Q13 Exchange Preview

Loading...
Loading...
In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group
CME
, and raised the price target from $65.00 to $69.00. In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.” CME Group closed on Friday at $60.48.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...